New Delhi: Drug firm Torrent Pharma today said its third manufacturing plant in Gujarat has obtained the Establishment Inspection Report ( EIR) from the US health regulator USFDA.
“Torrent Pharma has successfully obtained the Establishment Inspection Report from the USFDA for its plant located at Dahej SEZ, in Gujarat… the plant has also received approval from EU Germany,” Torrent Pharma said in a BSE filing.
It further said: “It was set up to cater mainly to the regulated international markets such as the US, Brazil, Germany etc.” With the approval, this plant is now the third plant of Torrent Pharma to receive USFDA approval, out of its 5 manufacturing plants.
“The company’s other FDA approved plants include the plant at Indrad, Gujarat and Pithampur (Indore), MP,” it added.
Shares of Torrent Pharma were trading at Rs 1,293.25, up 2.93 per cent, from the previous close on BSE.